Ascend Wellness Holdings, Inc.
AAWH · OTCMCIK 1756390fmd_0462JZ7XHHZJ7XQNM91771NH60Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 12 | 144 | 332 | 406 | 519 | 562 | 501 |
| Cost of revenue | 9 | 83 | 196 | 271 | 363 | 377 | 331 |
| Gross profit | 3 | 61 | 136 | 135 | 155 | 184 | 170 |
| Provision for credit losses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compensation and benefits | 9 | 16 | 56 | 62 | 75 | 76 | 66 |
| Total operating expenses | 29 | 53 | 153 | 142 | 159 | 179 | 187 |
| Operating income | (26) | 8 | (17) | (8) | (4) | 5 | (17) |
| Interest expense | 6 | 13 | 64 | 32 | 37 | 45 | 51 |
| Other non-operating income (expense) | (6) | (13) | (64) | (32) | (11) | (45) | (50) |
| Income before taxes | (33) | (5) | (81) | (39) | (15) | (40) | (67) |
| Income tax expense | 1 | 19 | 42 | 42 | 33 | 45 | 51 |
| Net income from continuing operations | (33) | (24) | (123) | (81) | (48) | (85) | (118) |
| Net income | (32) | (25) | (123) | (81) | (48) | (85) | (118) |